Versant Venture Management as of March 31, 2021
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 11 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 36.9 | $190M | 1.6M | 121.85 | |
| Passage Bio Common Stock (PASG) | 16.9 | $87M | 5.0M | 17.48 | |
| Aligos Therapeutics Common Stock (ALGS) | 14.6 | $75M | 3.3M | 22.74 | |
| Adverum Biotechnologies Common Stock | 9.7 | $50M | 5.1M | 9.86 | |
| Gritstone Oncology Common Stock (GRTS) | 8.2 | $42M | 4.5M | 9.43 | |
| Crinetics Pharmaceuticals Common Stock (CRNX) | 6.0 | $31M | 2.0M | 15.28 | |
| Akero Therapeutics Common Stock (AKRO) | 3.5 | $18M | 618k | 29.01 | |
| Flexion Therapeutics Common Stock | 2.3 | $12M | 1.3M | 8.95 | |
| Aprea Therapeutics Common Stock | 1.3 | $6.4M | 1.3M | 5.10 | |
| CymaBay Therapeutics Common Stock | 0.5 | $2.5M | 544k | 4.54 | |
| Clovis Oncology Common Stock | 0.1 | $715k | 102k | 7.02 |
